Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Carcinosarcoma × dostarlimab × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Neoplasms 3 Osteosarcoma 2 Triple Negative Breast Neoplasms 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Pathologic Complete Response 1 Ovarian Carcinosarcoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Melanoma 1 Hodgkin Disease 1 Hepatoblastoma 1 Hemangiosarcoma 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Neuroendocrine 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Adrenocortical Carcinoma 1

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03651206 2025-12-19

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡